Oncopath Genomics is a trusted expert in diagnostics, providing high-quality gene expression prognostic predictive services for the personalized medicine arena to enable better management of patient care.
With a wide range of products, Oncopath Genomics is led by Dr. Emmanuel Zachariah, the founder and President CEO, who brings extensive postdoctoral training, and Mr. Harun Sevimli, the Director of International Business Development, who has vast experience in international trade and consulting.
Generated from the website